Skip to content

SKYSTAR BIO-PHARMACEUTICAL CO: 10-Q filed 2014-11-14

What SKYSTAR BIO-PHARMACEUTICAL CO reported in its quarterly report filed 2014-11-14 (fiscal Q3 2014): 41 published measures, 114 facts as tagged in accession 0001144204-14-068847.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-14
Fiscal period
fiscal Q3 2014
Accession
0001144204-14-068847 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SKYSTAR BIO-PHARMACEUTICAL CO filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-30171,608,461USD
At 2013-12-31136,223,427USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-3049,103,771USD
At 2013-12-3125,830,451USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-30122,504,690USD
At 2013-12-31110,392,976USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-3014,634,703USD
At 2013-12-318,142,296USD
At 2013-09-304,456,619USD
At 2012-12-3111,321,848USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-304,909,453USD92
2014-01-01 to 2014-09-308,695,663USD273
2013-07-01 to 2013-09-303,734,197USD92
2013-01-01 to 2013-09-308,197,811USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-3063,685,817USD
At 2013-12-3154,990,154USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-07-01 to 2014-09-308,487,425shares92
2014-01-01 to 2014-09-307,959,506shares273
2013-07-01 to 2013-09-307,617,726shares92
2013-01-01 to 2013-09-307,615,733shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-07-01 to 2014-09-308,574,462shares92
2014-01-01 to 2014-09-308,050,359shares273
2013-07-01 to 2013-09-307,617,726shares92
2013-01-01 to 2013-09-307,615,733shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.58USD/shares92
2014-01-01 to 2014-09-301.09USD/shares273
2013-07-01 to 2013-09-300.49USD/shares92
2013-01-01 to 2013-09-301.08USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.57USD/shares92
2014-01-01 to 2014-09-301.08USD/shares273
2013-07-01 to 2013-09-300.49USD/shares92
2013-01-01 to 2013-09-301.08USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-07-01 to 2014-09-30712,934USD92
2014-01-01 to 2014-09-301,825,350USD273
2013-07-01 to 2013-09-30781,977USD92
2013-01-01 to 2013-09-301,800,018USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-3029,613,684USD
At 2013-12-3128,269,155USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-09-30209,523USD273
2013-01-01 to 2013-09-303,227USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-09-305,399,574USD92
2014-01-01 to 2014-09-309,939,652USD273
2013-07-01 to 2013-09-304,737,701USD92
2013-01-01 to 2013-09-3010,354,234USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-30120,861,819USD
At 2013-12-3188,615,112USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-07-01 to 2013-09-30154,792USD92
2013-01-01 to 2013-09-30565,252USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-3048,307,521USD
At 2013-12-3125,028,321USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-309,400,410USD
At 2013-12-313,303,531USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-12-315,012,602USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-09-3035,346,521USD
At 2013-12-3111,009,498USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-303,363,194USD92
2014-01-01 to 2014-09-308,004,921USD273
2013-07-01 to 2013-09-303,476,016USD92
2013-01-01 to 2013-09-306,416,659USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-09-3023,107,891USD
At 2013-12-3125,903,586USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-308,762,768USD92
2014-01-01 to 2014-09-3017,944,573USD273
2013-07-01 to 2013-09-308,213,717USD92
2013-01-01 to 2013-09-3016,770,893USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-07-01 to 2014-09-30378,487USD92
2014-01-01 to 2014-09-301,181,680USD273
2013-07-01 to 2013-09-30324,353USD92
2013-01-01 to 2013-09-30417,740USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-308,499,314shares
At 2013-12-317,604,800shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-09-3010,974,423USD
At 2013-12-3111,811,383USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-09-3037,292,003USD
At 2013-12-3134,747,082USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-09-307,678,319USD
At 2013-12-316,477,927USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-09-305,012,602USD
At 2013-12-315,237,255USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-31802,130USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2014-09-300USD
At 2013-12-310USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-305,622,387USD92
2014-01-01 to 2014-09-3010,521,013USD273
2013-07-01 to 2013-09-304,516,174USD92
2013-01-01 to 2013-09-309,997,829USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-07-01 to 2014-09-304,904,517USD92
2014-01-01 to 2014-09-307,858,703USD273
2013-07-01 to 2013-09-304,247,478USD92
2013-01-01 to 2013-09-3010,774,219USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-301,903,304USD92
2014-01-01 to 2014-09-304,537,024USD273
2013-07-01 to 2013-09-301,885,219USD92
2013-01-01 to 2013-09-303,785,302USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-07-01 to 2014-09-30378,518USD92
2014-01-01 to 2014-09-301,249,569USD273
2013-07-01 to 2013-09-30456,392USD92
2013-01-01 to 2013-09-301,086,914USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-07-01 to 2014-09-304,807USD92
2014-01-01 to 2014-09-30178,755USD273
2013-07-01 to 2013-09-3032,757USD92
2013-01-01 to 2013-09-3028,908USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-01 to 2014-09-30222,813USD92
2014-01-01 to 2014-09-30581,361USD273
2013-07-01 to 2013-09-30-221,527USD92
2013-01-01 to 2013-09-30-356,405USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-363,865USD273
2013-01-01 to 2013-09-30-339,618USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-3026,378,763USD273
2013-01-01 to 2013-09-3017,685,435USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-2,609,336USD273
2013-01-01 to 2013-09-303,775,636USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-306,129,382USD273
2013-01-01 to 2013-09-30-513,989USD273

Inspect the source

Entity
SKYSTAR BIO-PHARMACEUTICAL CO / CIK 0001076939
Captured
SEC response SHA-256
d8a65cf54c4bf27fa61797f1bd20f2af91d87c7c6e9bd44fc78d05c68ff517d1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001076939.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))